United States Secretary of Agriculture Tom Vilsack testifies before a House Appropriations Subcommittee in Washington March 14, 2014. REUTERS/Gary Cameron A planned EU/U.S. trade deal needs to sweep away "non-scientific barriers" that prevent U.S. farmers from selling many genetically modified crops and some meat from hormone-treated animals in Europe, the U.S. agriculture secretary said on Tuesday.
The two sides aim to create the world's largest free-trade pact, whose advocates say it could boost their economies by $100 billion a year each. But after a year of talks on the Transatlantic Trade and Investment Partnership (TTIP), agriculture is emerging as one of the most difficult areas.
The European Union has ruled out importing meat from animals injected with hormones and said that it will not simply open the door to GM crops.
U.S. Agriculture Secretary Tom Vilsack said difficult issues needed to be addressed, with the common goal of opening markets and eliminating "non-scientific barriers".
"Science is a common language ... We will be working towards making sure that whatever agreements are reached, they are consistent with sound science," he told a media briefing during a visit to Brussels.
In the case of GM crops, the EU has cleared for import some 50 of about 450 commercial strains. The bloc takes in about 30 million tonnes a year for its cattle, pigs and poultry, but EU retailers hardly stock any GM food because of widespread consumer resistance.
Vilsack said it was not acceptable that it took four years or more for GM strains to gain access to European markets after winning clearance from the European Food Safety Authority. That compared with a U.S. norm of about 18 months.
The United States is demanding the regulatory process be harmonised.
Ecological group Greenpeace says GM crops are part of large-scale intensive farming which degrades soils and pollutes water. It says they create herbicide-resistant superweeds that require more pesticides and are not proven to be safe to eat, with much of the research funding coming from industry.
Vilsack said the U.S. government was very concerned about suggestions that GM products posed a safety risk, which he said was not borne out by science.
Labelling, suggested by some in Europe, would not be a solution, he said. U.S. labels, he said, typically concerned nutritional information or carried a specific warning, for example to alert those with a peanut allergy.
Insisting on a label indicating a foodstuff contained a GM product risked sending a wrong impression that this was a safety issue, he said.